RETRACTED: Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line
Authors:
- 1 October 2021
- journal article
- retracted article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 142, 111960
Abstract
No abstract availableKeywords
Funding Information
- King Abdulaziz University (RG-24-130-42)
- Deanship of Scientific Research, King Saud University (RG-24-130-42)
- Department of Sport and Recreation, Government of Western Australia (RG-24-130-42)
This publication has 27 references indexed in Scilit:
- Hepatocellular Carcinoma: Therapeutic Guidelines and Medical TreatmentLiver Cancer, 2016
- Strigolactones: new plant hormones in actionPlanta, 2016
- Chitosan and carboxymethyl-chitosan capping ligands: Effects on the nucleation and growth of hydroxyapatite nanoparticles for producing biocomposite membranesMaterials Science and Engineering: C, 2016
- Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinomaMolecular Medicine Reports, 2015
- Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.Oncotarget, 2014
- Chemopreventive strategies in hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2013
- S-adenosylmethionine metabolism and liver diseaseAnnals of Hepatology, 2013
- Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cellsBreast Cancer Research and Treatment, 2012
- Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progressionHepatology, 2012
- Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor modelInternational Journal of Cancer, 2010